In prostate cancer stem cells, PER3 has been shown to enhance the expression of BMAL1, resulting in the phosphorylation of β-catenin and subsequent activation of the Wnt/β-catenin pathway (Li et al. 2021b). The gene discussed is PER3; the disease is prostate carcinoma.